MOH
Molina Healthcare, Inc. NYSE Listed Jul 2, 2003$191.87
Mkt Cap $10.0B
52w Low $121.06
33.4% of range
52w High $333.00
50d MA $153.44
200d MA $164.69
P/E (TTM)
21.6x
EV/EBITDA
8.7x
P/B
2.4x
Debt/Equity
1.0x
ROE
4.6%
P/FCF
-13.9x
RSI (14)
—
ATR (14)
—
Beta
0.55
50d MA
$153.44
200d MA
$164.69
Avg Volume
1.9M
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
200 Oceangate · Long Beach, CA 90802 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | AMC | 1.57 | 2.35 | +49.7% | 153.00 | +7.7% | +14.2% | +15.0% | +17.1% | +21.2% | +28.4% | — |
| Feb 5, 2026 | AMC | 0.43 | -2.75 | -739.5% | 176.84 | -28.8% | -25.5% | -27.9% | -29.1% | -30.6% | -28.3% | — |
| Oct 22, 2025 | AMC | 3.97 | 1.84 | -53.7% | 195.13 | -19.5% | -17.5% | -16.3% | -16.9% | -16.5% | -17.9% | — |
| Jul 23, 2025 | AMC | 5.62 | 5.48 | -2.5% | 190.25 | -9.0% | -16.8% | -13.3% | -13.7% | -15.3% | -15.9% | — |
| Apr 23, 2025 | AMC | 5.97 | 6.08 | +1.8% | 332.00 | +0.4% | -5.5% | -5.3% | -3.6% | -3.7% | -1.5% | — |
| Feb 5, 2025 | AMC | 5.74 | 5.05 | -12.0% | 317.01 | -9.4% | -10.1% | -10.4% | -9.6% | -13.9% | -15.9% | — |
| Oct 23, 2024 | AMC | 5.81 | 6.01 | +3.4% | 275.00 | +18.2% | +17.7% | +18.4% | +14.6% | +17.5% | +17.9% | — |
| Jul 24, 2024 | AMC | 5.50 | 5.86 | +6.5% | 288.72 | +10.1% | +12.3% | +16.2% | +15.3% | +21.5% | +18.2% | — |
| Apr 24, 2024 | AMC | 5.59 | 5.73 | +2.5% | 367.41 | -4.1% | -4.1% | -6.9% | -6.4% | -6.9% | -7.8% | — |
| Feb 7, 2024 | AMC | 4.35 | 4.38 | +0.7% | 362.10 | +0.8% | +5.4% | +7.3% | +8.4% | +8.9% | +10.5% | — |
| Oct 25, 2023 | AMC | 4.88 | 5.05 | +3.5% | 336.45 | -9.3% | -1.5% | -0.1% | -2.5% | -1.0% | +0.1% | — |
| Jul 26, 2023 | AMC | 5.10 | 5.65 | +10.8% | 311.17 | +2.1% | -1.2% | -3.1% | -2.1% | -2.9% | -2.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | BofA Securities | Upgrade | Underperform → Buy | $250 | $185.46 | $189.96 | +2.4% | +5.9% | +4.9% | +3.9% | +5.4% | +3.6% |
| Apr 27 | Truist | Maintains | Hold → Hold | — | $175.94 | $177.96 | +1.1% | +1.9% | +5.4% | +11.7% | +10.6% | +9.5% |
| Apr 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $175.94 | $177.96 | +1.1% | +1.9% | +5.4% | +11.7% | +10.6% | +9.5% |
| Apr 24 | UBS | Maintains | Neutral → Neutral | — | $174.70 | $175.12 | +0.2% | +0.7% | +2.6% | +6.2% | +12.5% | +11.4% |
| Apr 24 | Barclays | Maintains | Underweight → Underweight | — | $174.70 | $175.12 | +0.2% | +0.7% | +2.6% | +6.2% | +12.5% | +11.4% |
| Apr 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $174.70 | $175.12 | +0.2% | +0.7% | +2.6% | +6.2% | +12.5% | +11.4% |
| Mar 12 | UBS | Maintains | Neutral → Neutral | — | $146.80 | $145.24 | -1.1% | +1.7% | +1.6% | -0.2% | -1.9% | +1.2% |
| Mar 12 | Mizuho | Maintains | Outperform → Outperform | — | $146.80 | $145.24 | -1.1% | +1.7% | +1.6% | -0.2% | -1.9% | +1.2% |
| Mar 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $144.81 | $144.00 | -0.6% | +3.6% | +2.0% | -0.2% | +0.8% | -2.4% |
| Feb 20 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $148.24 | $145.93 | -1.6% | +1.9% | +5.4% | +0.0% | -1.8% | -1.3% |
| Feb 17 | Truist | Maintains | Hold → Hold | — | $135.35 | $135.07 | -0.2% | +0.2% | +5.4% | +9.5% | +11.6% | +15.4% |
| Feb 12 | Goldman Sachs | Maintains | Neutral → Neutral | — | $122.65 | $123.00 | +0.3% | +3.3% | +10.4% | +10.6% | +16.3% | +20.9% |
| Feb 10 | Barclays | Maintains | Underweight → Underweight | — | $127.53 | $128.00 | +0.4% | -1.6% | -3.8% | -0.6% | +6.1% | +6.4% |
| Feb 9 | TD Cowen | Maintains | Hold → Hold | — | $131.72 | $132.00 | +0.2% | -3.2% | -4.8% | -6.9% | -3.8% | +2.8% |
| Feb 9 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $131.72 | $132.00 | +0.2% | -3.2% | -4.8% | -6.9% | -3.8% | +2.8% |
| Jan 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $184.73 | $185.53 | +0.4% | -4.5% | -0.7% | -1.7% | -1.6% | -2.1% |
| Jan 5 | Barclays | Maintains | Underweight → Underweight | — | $178.46 | $180.25 | +1.0% | +2.4% | +3.5% | -1.2% | +2.8% | +1.7% |
| Nov 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $143.52 | $142.64 | -0.6% | -1.7% | -3.5% | -4.2% | -4.7% | -1.6% |
| Oct 24 | Goldman Sachs | Maintains | Neutral → Neutral | — | $161.00 | $160.40 | -0.4% | +1.4% | +0.7% | +1.1% | -0.4% | -6.1% |
| Oct 24 | Barclays | Downgrade | Equal Weight → Underweight | — | $161.00 | $160.40 | -0.4% | +1.4% | +0.7% | +1.1% | -0.4% | -6.1% |
| Oct 24 | UBS | Maintains | Neutral → Neutral | — | $161.00 | $160.40 | -0.4% | +1.4% | +0.7% | +1.1% | -0.4% | -6.1% |
| Oct 24 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $161.00 | $160.40 | -0.4% | +1.4% | +0.7% | +1.1% | -0.4% | -6.1% |
| Oct 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $194.27 | $192.32 | -1.0% | +0.3% | -1.0% | -2.9% | -0.8% | +1.7% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $200.57 | $203.86 | +1.6% | +1.3% | +1.2% | -0.1% | -3.3% | -3.1% |
| Sep 5 | Bernstein | Maintains | Outperform → Outperform | — | $170.83 | $170.73 | -0.1% | +2.2% | +2.8% | +6.3% | +4.9% | +10.3% |
| Sep 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $177.04 | $170.00 | -4.0% | -3.5% | -1.4% | -0.8% | +2.5% | +1.2% |
| Aug 26 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $175.17 | $174.43 | -0.4% | -0.2% | +0.5% | -0.3% | +3.2% | +4.6% |
| Aug 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $159.63 | $166.51 | +4.3% | +4.9% | +6.0% | +8.9% | +8.8% | +8.3% |
| Jul 29 | JP Morgan | Maintains | Neutral → Neutral | — | $164.19 | $160.28 | -2.4% | -1.9% | -2.6% | -3.8% | -5.5% | -3.7% |
| Jul 25 | Baird | Maintains | Neutral → Neutral | — | $158.22 | $157.80 | -0.3% | +4.3% | +3.8% | +1.8% | +1.1% | -0.2% |
| Jul 25 | Truist | Downgrade | Buy → Hold | — | $158.22 | $157.80 | -0.3% | +4.3% | +3.8% | +1.8% | +1.1% | -0.2% |
| Jul 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $158.22 | $157.80 | -0.3% | +4.3% | +3.8% | +1.8% | +1.1% | -0.2% |
| Jul 25 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $158.22 | $157.80 | -0.3% | +4.3% | +3.8% | +1.8% | +1.1% | -0.2% |
| Jul 25 | UBS | Maintains | Neutral → Neutral | — | $158.22 | $157.80 | -0.3% | +4.3% | +3.8% | +1.8% | +1.1% | -0.2% |
| Jul 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $180.64 | $182.71 | +1.1% | +5.3% | -12.4% | -8.6% | -9.1% | -10.8% |
| Jul 16 | Truist | Maintains | Buy → Buy | — | $214.61 | $213.64 | -0.5% | +0.7% | -4.8% | -14.7% | -17.8% | -15.8% |
| Jul 11 | Mizuho | Maintains | Outperform → Outperform | — | $228.58 | $226.50 | -0.9% | -3.1% | -4.2% | -6.1% | -5.5% | -10.6% |
| Jul 10 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $237.22 | $233.00 | -1.8% | -3.6% | -6.6% | -7.7% | -9.5% | -8.9% |
| Jun 9 | Barclays | Maintains | Equal Weight → Equal Weight | — | $296.88 | $299.99 | +1.0% | +0.0% | -0.4% | -0.8% | -1.1% | +0.4% |
| Jun 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $305.04 | $301.98 | -1.0% | -2.5% | -3.8% | -4.1% | -3.8% | -2.7% |
| Apr 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $313.81 | $314.04 | +0.1% | +0.2% | +2.0% | +1.9% | +4.2% | -0.2% |
| Apr 15 | Baird | Downgrade | Outperform → Neutral | — | $348.57 | $346.83 | -0.5% | -3.7% | -4.6% | -7.6% | -13.3% | -7.9% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $342.68 | $340.71 | -0.6% | +0.7% | +1.7% | -2.1% | -3.0% | -6.0% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $330.66 | $329.99 | -0.2% | +2.9% | +3.6% | +4.3% | +5.4% | +1.5% |
| Mar 5 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $306.49 | $309.29 | +0.9% | +1.8% | +5.7% | +6.8% | +8.7% | +6.0% |
| Mar 3 | Mizuho | Maintains | Outperform → Outperform | — | $301.12 | $302.81 | +0.6% | +0.6% | +1.8% | +3.6% | +7.5% | +8.7% |
| Feb 19 | Truist | Maintains | Buy → Buy | — | $268.56 | $268.60 | +0.0% | +6.8% | +8.5% | +5.7% | +7.0% | +13.9% |
| Feb 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $285.01 | $286.30 | +0.5% | -0.4% | +0.5% | -4.2% | -6.5% | -5.0% |
| Feb 7 | UBS | Maintains | Neutral → Neutral | — | $285.01 | $286.30 | +0.5% | -0.4% | +0.5% | -4.2% | -6.5% | -5.0% |
| Feb 6 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $317.01 | $287.09 | -9.4% | -10.1% | -10.4% | -9.6% | -13.9% | -15.9% |
No insider trades available.
8-K
Molina Healthcare, Inc. -- 8-K Filing
Molina Healthcare reaffirmed its full-year 2026 premium revenue and adjusted earnings guidance despite first quarter results, indicating management confidence in sustained operational performance.
Apr 22
8-K · 7.01
! Medium
Molina Healthcare, Inc. -- 8-K 7.01: Regulation FD Disclosure
Molina Healthcare will reaffirm its 2026 guidance of at least $3.20 GAAP diluted EPS and $5.00 adjusted diluted EPS during upcoming investor meetings and the TD Cowen Health Care Conference.
Feb 26
8-K · 1.01
! Medium
Molina Healthcare, Inc. -- 8-K 1.01: Financing / Debt Agreement
Molina Healthcare amended its credit agreement, likely modifying borrowing terms or covenants to provide greater financial flexibility for operations and potential strategic initiatives.
Feb 6
8-K
Molina Healthcare, Inc. -- 8-K Filing
Molina Healthcare reported a fourth quarter 2025 GAAP loss per diluted share of $3, while providing 2026 revenue and earnings guidance to investors.
Feb 5
Data updated apr 26, 2026 12:59pm
· Source: massive.com